Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The German generics market recorded revenues of $24.3 billion in 2024, representing a compound annual growth rate (CAGR) of 2.8% between 2019 and 2024.
- Market consumption volume increased with a CAGR of 1.4% between 2019 and 2024, reaching a total of 85.2% of total pharma volume in 2024.
- In 2024, the revenue of the German generics market experienced an annual growth of 3.8%. The market’s growth is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, increasing the demand for affordable, long-term medications.
Report Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Germany
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany generics market with five year forecasts
Reasons to Buy
- What was the size of the Germany generics market by value in 2024?
- What will be the size of the Germany generics market in 2029?
- What factors are affecting the strength of competition in the Germany generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's generics market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teva Pharmaceutical Industries Ltd
- Novartis AG
- Bayer AG
- Stada Arzneimittel AG
